Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2020-12-04 2020-02-20
Drug Identification Number 02493357 02493357
Brand name RIVA LEUCOVORIN RIVA LEUCOVORIN
Common or Proper name Riva Leucovorin Riva Leucovorin
Company Name LABORATOIRE RIVA INC. LABORATOIRE RIVA INC.
Ingredients LEUCOVORIN LEUCOVORIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 24 24
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-02-20 2020-02-20
Actual start date 2020-02-20 2020-02-20
Estimated end date Unknown Unknown
Actual end date 2020-09-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments